CorMedix Inc.
CRMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001410098
No open-market purchases or sales by CorMedix Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $345.5M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding CorMedix Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 99 | 1 | 102 | +4 |
| Shares | 17.2M | 3.55M | 19.1M | +5.54M (+40.7%) |
| Value | $74.3M | $15.4M | $154.7M | +$95.8M (+162.5%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held CorMedix Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 3,656,294 | $29.5M | 0.00% |
| Rosalind Advisors, Inc. | 1,475,000 | $11.9M | 7.91% |
| Kennedy Capital Management, Inc. | 379,944 | $3.07M | 0.07% |
| J. Goldman & Co LP | 142,440 | $1.15M | 0.05% |
| Parallax Volatility Advisers, L.P. | 80,143 | $647.6K | 0.02% |
| Campbell & CO Investment Adviser LLC | 78,345 | $633.0K | 0.05% |
| ExodusPoint Capital Management, LP | 48,865 | $395.0K | 0.00% |
| SG Americas Securities, LLC | 18,833 | $152.0K | 0.00% |
| Creative Planning | 15,917 | $128.6K | 0.00% |
| Intech Investment Management LLC | 14,695 | $118.7K | 0.00% |
| Palumbo Wealth Management LLC | 12,366 | $99.9K | 0.04% |
| AlphaMark Advisors, LLC | 12,000 | $97.0K | 0.03% |
| ProShare Advisors LLC | 10,379 | $83.9K | 0.00% |
| Signaturefd, LLC | 1,000 | $8.08K | 0.00% |
| Quantbot Technologies LP | 628 | $5.07K | 0.00% |
| Lindbrook Capital, LLC | 81 | $654 | 0.00% |
| Sterling Capital Management LLC | 65 | $525 | 0.00% |
| Capital Performance Advisors LLP | 47 | $380 | 0.00% |
| National Bank of Canada | 2 | $16 | 0.00% |
Sold out (15)
Institutions that held CorMedix Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Nomura Holdings Inc | 1,422,226 | $6.16M |
| Renaissance Technologies LLC | 160,734 | $696.0K |
| Centiva Capital, LP | 31,787 | $137.6K |
| Dimensional Fund Advisors LP | 21,601 | $93.5K |
| Dynamic Technology Lab Private Ltd | 16,772 | $73.0K |
| Balyasny Asset Management LLC | 16,446 | $71.2K |
| Verition Fund Management LLC | 13,624 | $59.0K |
| Toroso Investments, LLC | 12,024 | $52.1K |
| Engineers Gate Manager LP | 11,843 | $51.3K |
| Ameriprise Financial Inc | 11,697 | $50.6K |
| AQR Capital Management LLC | 11,189 | $48.4K |
| Principal Financial Group Inc | 10,229 | $44.3K |
| Pinnacle Wealth Management Advisory Group, LLC | 10,000 | $43.3K |
| Mather Group, LLC. | 523 | $2.22K |
| Parallel Advisors, LLC | 249 | $1.08K |
Not filed for Q3 2024 yet (1)
Institutions that held CorMedix Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,553,474 | $15.4M |